Blindsight: this is Neuralink's chip that would allow seeing in infrared

Neuralink plans to begin implanting its new chip Blindsight in humans within the next 6 to 12 months. The goal is to restore vision, even in people who have been blind since birth, and enhance it with capabilities such as seeing in infrared or ultraviolet.

The project aims to open the door to a new form of augmented vision that could change human perception as we know it.

Neuralink planea empezar a implantar su nuevo chip Blindsight en humanos

What is Blindsight and how does it work?

Blindsight is a brain implant designed by Neuralink to connect the brain's visual cortex directly to a technological interface. This eliminates the need for the optic nerve to function properly.

The idea is to generate a digital image that the brain can interpret, even in people who have never seen. The first version would provide blurry vision, which will be improved over time.

"Like having superpowers"

According to Elon Musk, Blindsight could allow people to see spectrums such as infrared or ultraviolet, creating an unprecedented sensory experience. "It's like having superpowers," he stated in an interview with the media outlet Neo Niche.

Musk lanzó fuertes críticas contra la ley que busca ampliar la financiación a las fuerzas armadas

He believes this technology will be key for what he defines as "cognitive enhancement". A way to boost human intelligence and senses beyond their biological limits.

Neuralink has already tested Blindsight in monkeys

During 2024, the company tested preliminary versions of the chip in monkeys, which led to protests from animal rights organizations and an investigation by U.S. health authorities.

Despite the controversies, the FDA recognized Blindsight as an innovative device. This allows its clinical research to be accelerated and progress toward the first human trials.

A new stage for Neuralink

This announcement comes after Neuralink's first successful trials with human patients, who managed to control a cursor with their minds. The first implant had failures, but the company corrected course in subsequent cases.